The use and abuse of antibiotics, including in management of pulmonary manifestations in cystic fibrosis.
D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D003550:Cystic Fibrosis / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D008171:Lung Diseases / Q000188:drug therapy* / Q000209:etiology; D019966:Substance-Related Disorders; D014031:Tobramycin / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D014031:Tobramycin